What’s the STORY
What’s the STORY (Serum Testing of Representative Youngsters) Sero-epidemiological survey of England
Type: Observational (sero-epidemiology study)
Site and lead:
- Royal Manchester Children’s Hospital: Dr Stephen Hughes
Patient group: Children
Funder: NIHR/UKRI
Sponsor: University of Oxford (Oxford Vaccine Group)
More about What’s the STORY
- Read more on our news story about What’s the STORY
- What’s the STORY is a nationally-prioritised COVID-19 study. See the full list Urgent Public Health COVID-19 Studies on the NIHR website.
Initially designed to assess serological protection against vaccine preventable diseases such as diphtheria and group C meningococcus in 0 to 24-year-olds, following the COVID-19 outbreak the study has been adapted to evaluate the prevalence of antibodies against novel coronavirus SARS-CoV-2 in healthy children and adolescents.
Blood samples will be collected from 3,500 healthy 0 to 24-year-olds, accompanied by questionnaires on health and demographic data.
Recruitment is via invitation letter only and is sent out centrally from the study sponsor to a pre-selected cohort of patients within our area. Only families who receive this letter are eligible to take part.
